Allogene Therapeutics Inc (NASDAQ: ALLO) Disappoints Wall Street With -6.58% Stock Price Drop

In the last trading session, 1.59 million Allogene Therapeutics Inc (NASDAQ:ALLO) shares changed hands as the company’s beta touched 0.82. With the company’s per share price at $3.55 changed hands at -$0.25 or -6.58% during last session, the market valuation stood at $600.27M. ALLO’s last price was a discount, traded about -94.08% off its 52-week high of $6.89. The share price had its 52-week low at $2.23, which suggests the last value was 37.18% up since then. When we look at Allogene Therapeutics Inc’s average trading volume, we note the 3-month average coming to 2.40 million.

Allogene Therapeutics Inc (NASDAQ:ALLO) trade information

Instantly ALLO was in red as seen at the end of in last trading. With action -10.80%, the performance over the past five days has been red. The drop to weekly highs of 4.25 subtracted -6.58% to the stock’s daily price. The company’s shares are showing year-to-date upside of 10.59%, with the 5-day performance at -10.80% in the red. However, in the 30-day time frame, Allogene Therapeutics Inc (NASDAQ:ALLO) is -21.02% down.

Allogene Therapeutics Inc (ALLO) estimates and forecasts

Data shows that the Allogene Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 19.93% over the past 6 months, a 15.92% in annual growth rate that is considerably higher than the industry average of 13.00%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 22.18%. The 2024 estimates are for Allogene Therapeutics Inc earnings to increase by 21.14%, but the outlook for the next 5-year period is at 1.00% per year.